Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)

被引:0
作者
Esmeralda Núñez Cuadros
Joan Calzada-Hernández
Daniel Clemente
Sara Guillén Martín
Laura Fernández Silveira
María José Lirola-Cruz
Alfredo Tagarro
Marisol Camacho Lovillo
Rosa María Alcobendas Rueda
Agustín López López
Miren Satrustegi Aritziturri
Cristina Calvo
机构
[1] UGC Pediatría,Pediatric Rheumatology Unit
[2] Hospital Regional Universitario de Málaga,Unitat de Reumatologia Pediàtrica, Servei de Pediatria
[3] Instituto de Investigación Biomédica de Málaga (IBIMA),Pediatric Rheumatology Unit
[4] Hospital Sant Joan de Déu,Department of Paediatrics
[5] Hospital Infantil Universitario,Servicio de Inmunología
[6] Niño Jesús,Department of Paediatríc Rheumatology
[7] Hospital Universitario de Getafe,Pediatrics Department, Instituto de Investigación 12 de Octubre (imas12)
[8] CIBERINFEC ISCIII,Department of Pediatric Rheumatology
[9] Getafe,Department of Paediatrics
[10] Reumatología e Infectología Pediátricas,Servicio de Pediatría
[11] Hospital Universitario Virgen del Rocío,Department of Pediatrics, Infectious and Tropical Diseases
[12] Instituto Hispalense de Pediatría,undefined
[13] Hospital Universitario Infanta Sofía,undefined
[14] Universidad Europea,undefined
[15] La Paz Children’s Hospital,undefined
[16] Hospital Universitario Puerta de Hierro,undefined
[17] Hospital Universitario Donostia,undefined
[18] Hospital Universitario La Paz,undefined
[19] and La Paz Research Institute (IdiPaz). CIBERINFEC. ISCIII,undefined
[20] Translational Research Network of Pediatric Infectious Diseases (RITIP),undefined
来源
European Journal of Pediatrics | 2022年 / 181卷
关键词
Infections; Screening; Prophylaxis; Vaccination; Immune-mediated rheumatic diseases; Consensus;
D O I
暂无
中图分类号
学科分类号
摘要
This study provides practical recommendations on infection screening in pediatric patients with immune-mediated rheumatic diseases and immunosuppressive therapies. For this reason, a qualitative approach was applied. A narrative literature review was performed via Medline. Primary searches were conducted using Mesh and free texts to identify articles that analyzed data on infections and vaccinations in pediatric patients with immune-mediated rheumatic diseases and immunosuppressive therapies. The results were presented and discussed in a nominal group meeting, comprising a committee of 12 pediatric rheumatologists from the infections prevention and treatment working group of the Spanish Society of Pediatric Rheumatology. Several recommendations were generated. A consensus procedure was implemented via a Delphi process that was extended to members of the Spanish Society of Pediatric Rheumatology and Vaccine Advisory Committee of the Spanish Association of Pediatrics. Participants to the process produced a score ranging from 0 = totally disagree to 10 = totally agree. Agreement was considered if at least 70% of participants voted ≥ 7. The literature review included more than 400 articles. Overall, 63 recommendations were generated (21 on infection screening) voted by 59 pediatric rheumatologists and other pediatric specialists, all of them achieving the pre-established agreement level. The recommendations on screening cover all the procedures (serology, assessment of risk factors, and other clinical activities) connected with the screening for infections including tuberculosis; hepatitis A, B, and C viruses; measles; mumps; rubella; diphtheria; and other infections. 
引用
收藏
页码:2343 / 2354
页数:11
相关论文
共 269 条
[31]  
Beglinger C(2015)Diphtheria, tetanus and poliovirus antibody persistence 5 years after vaccination of pre-schoolers with two different diphtheria, tetanus and inactivated poliomyelitis vaccines (Td-IPV or DT-IPV) and immune responses to a booster dose of DTaP-IPV Vaccine 33 68-1384
[32]  
Dudler J(2008)A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines BMC Infect Dis 8 1379-129
[33]  
Mottet C(2019)Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy Clin Microbiol Infect 25 119-400
[34]  
Nicod L(2014)Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination Hepat Mon 14 395-1649
[35]  
Seibold F(2011)Hepatitis B and the need for a booster dose Clin Infect Dis 53 1644-28
[36]  
Villiger PM(2005)Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study Lancet 366 25-38
[37]  
Fonseca JE(2017)Mechanisms and prevention of vertical transmission in chronic viral hepatitis J Clin Transl Hepatol 5 33-168
[38]  
Canhao H(2010)Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up Infection 38 166-239
[39]  
Silva C(2012)Persistence of long-term immunity to hepatitis B among adolescents immunized at birth Vaccine 30 235-1657
[40]  
Miguel C(2016)Viral hepatitis screening guideline before biological drug use in rheumatic patients Eur J Rheumatol 3 1649-540